Challenges and choices in the pharmacological treatment of non-severe pediatric asthma: A commentary for the practicing physician()

In recent years, asthma research has focused intensely on the severe part of the disease spectrum, leading to new treatments, mostly therapeutic monoclonal antibodies. However, severe asthma accounts for not more than 2% of asthma in the pediatric population. Therefore, non-severe asthma remains a m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalayci, Omer, Abdelateef, Hanan, Pozo Beltrán, César Fireth, El-Sayed, Zeinab A., Gómez, René Maximiliano, Hossny, Elham, Morais-Almeida, Mário, Nieto, Antonio, Phipatanakul, Wanda, Pitrez, Paulo, Wong, Gary Wk., Xepapadaki, Paraskevi, Papadopoulos, Nikolaos G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796770/
https://www.ncbi.nlm.nih.gov/pubmed/31641403
http://dx.doi.org/10.1016/j.waojou.2019.100054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796770/
https://www.ncbi.nlm.nih.gov/pubmed/31641403
http://dx.doi.org/10.1016/j.waojou.2019.100054

Ejemplares similares